Bajaj, Archna
Rader, Daniel J. http://orcid.org/0000-0002-9245-9876
Article History
First Online: 6 April 2020
Competing interests
: D. J. R. serves on the Scientific Advisory Board for Alnylam, which makes small interfering RNA therapeutics, and for Novartis, which has licensed AKCEA-APO(a)-L<sub>Rx</sub>.